G

Garuda Therapeutics

51 employees

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
stem cells
ipsc
blood diseases
gene therapy
platform
cell therapy manufacturing
sickle cell disease
hematologic malignancies
beta thalassemia
clinical
Health Care
cell and gene therapy
cell therapy
Therapeutics
manufacturing
research and development
hsc
clinical trials
start-up
bone marrow failure disease
Life Science
biotech

Date founded

2021

Funding rounds raised

Total raised

$72M

from 11 investors over 11 rounds

G

Garuda Therapeutics raised $62M on February 7, 2023

Investors: Sectoral Asset Management, Northpond Ventures, OrbiMed Advisors and Aisling Capital

G

Garuda Therapeutics raised $72M on September 23, 2021

Investors: Aisling Capital, Sectoral Asset Management, Tatleaux Partners, LLC, Northpond Ventures, Ridgeback Capital Management LLC, Monashee Investment Management LLC and OrbiMed Advisors

FAQ